1. Home
  2. MGY vs ARQT Comparison

MGY vs ARQT Comparison

Compare MGY & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

HOLD

Current Price

$21.89

Market Cap

4.0B

Sector

Energy

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.59

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGY
ARQT
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.3B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MGY
ARQT
Price
$21.89
$29.59
Analyst Decision
Hold
Strong Buy
Analyst Count
11
7
Target Price
$25.20
$24.83
AVG Volume (30 Days)
2.2M
1.8M
Earning Date
02-17-2026
10-28-2025
Dividend Yield
2.74%
N/A
EPS Growth
N/A
N/A
EPS
1.80
N/A
Revenue
$1,320,826,000.00
$317,929,000.00
Revenue This Year
$1.07
$85.51
Revenue Next Year
$2.41
$30.74
P/E Ratio
$12.17
N/A
Revenue Growth
0.68
129.21
52 Week Low
$19.09
$11.13
52 Week High
$26.84
$31.77

Technical Indicators

Market Signals
Indicator
MGY
ARQT
Relative Strength Index (RSI) 42.77 56.35
Support Level $21.53 $27.71
Resistance Level $22.28 $30.26
Average True Range (ATR) 0.42 1.02
MACD -0.02 -0.24
Stochastic Oscillator 17.75 74.59

Price Performance

Historical Comparison
MGY
ARQT

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: